Table 5.

The association between CONUT and clinicopathological features in patients with HNC

Variables	No. of studies	No. of patients	Effects model	OR (95%CI)	p	Heterogeneity
						I2(%)	Ph
Gender (male vs. female)	4	759	Fixed	0.72(0.45–1.15)	0.174	0	0.896
T stage (T3-T4 vs. T1-T2)	3	361	Fixed	3.21(1.94–5.31)	< 0.001	47.3	0.150
N stage (N1-N3 vs. N0)	3	361	Fixed	3.10(1.74–5.53)	< 0.001	0	0.594
TNM stage (III-IV vs. I-II)	3	646	Random	1.83(0.51–6.51)	0.351	85.3	0.001